🇪🇨 Country Profile

Ecuador

Fast-growing pharmaceutical trade with Ecuador

🇪🇨 $55.0M
All data from DGCIS India export records (fiscal year, April–March).
$55.0M
Scale
Ecuador's healthcare system receives $55.0M in Indian pharmaceutical products each year, affordable, quality medicine.
73%
Medicine
Primarily medicines (73%), supplemented by surgical & hospital supplies and vaccines.
3.4×
Trajectory
One of the faster-growing relationships, India's pharmaceutical supply to Ecuador has expanded 3.4× over the decade.
Context
Part of India's pharmaceutical supply network across Americas.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Ecuador, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $40.2M (72.6%) Surgical & Hospital Supplies $5.2M (9.4%) Vaccines $5.0M (9.1%) Medicine Ingredients $3.6M (6.5%) Traditional & Herbal $1.3M (2.4%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Ecuador Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Ecuador: $3.4M across 9 filings (2017-2023).